Learn More
Apexbio Technology LLC Imatinib (STI571) 152459-95-5 100mg

Supplier: Apexbio Technology LLC B2171100
Imatinib (STI571) (CAS 152459-95-5) is a small-molecule inhibitor targeting protein tyrosine kinases including Abl kinase platelet-derived growth factor receptor (PDGFR) and c-Kit It modulates kinase activity by inhibiting phosphorylation thereby regulating oncogenic signal transduction pathways Imatinib exerts its biological activity primarily by suppressing the phosphorylation activity of Abl kinase (IC50 0 025 M) PDGFR (IC50 0 1 M) and c-Kit (IC50 0 1 M) In cell-based assays Imatinib inhibits PDGFR phosphorylation induced by PDGF-AA and PDGF-BB and reduces c-Kit-mediated signal transduction involved in tumor cell proliferation Based on these pharmacological properties Imatinib holds research potential in oncology for investigating kinase-driven cellular processes and therapeutic interventions
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.